Precision medicine holds the promise of bringing the right treatment to the right patient at the right time with the upside of reduced undesirable effects. But the impact on healthcare costs are not clear. While targeting of conventional drugs through precision diagnostics may be relatively cost-effective and provide better performance and reduced side effects, fully personalised precision medicine treatments, such as cancer gene therapies, are generally high cost at least in the short term.